Command Palette

Search for a command to run...

pharmaids-pharmaceuticals

44.2-0.58%
Market Cap
₹156.80 Cr
Stock P/E
-12.02
ROCE
-28.16%
ROE
-25.19%
Book Value
₹15.31

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Laggard

Pharmaids Pharmaceuticals Ltd. shows significant underperformance across key financial metrics compared to its peers, with negative earnings and low efficiency ratios. The company is financially weak with high losses, low profitability, and low growth compared to industry leaders. It is positioned as a significant underperformer in the pharmaceutical sector.

Key Points
  • Pharmaids has negative EPS and ROE, indicating severe financial distress.
  • The company exhibits the lowest growth metrics, with no revenue growth over three years.
  • High debt levels compared to peers and negative profit margins highlight financial instability.
Top Performers
Cipla Ltd.

Strong profitability with a PE ratio of 23.73 and an impressive EPS growth of 66.76.

Dr. Reddy's Laboratories Ltd.

High ROE and ROA with solid profitability metrics, ranking well in terms of financial health.

Mankind Pharma Ltd.

Exceptional revenue growth and solid profitability metrics, indicating strong market performance.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.